Search results
Biomea Fusion Crashes 67% After FDA Puts Diabetes Treatment Studies On Hold
Investor's Business Daily· 57 minutes agoThe drug, BMF-291, was in early-stage testing for patients with type 1 and type 2 diabetes. The FDA...
Diabetes biotech stock tanks as FDA imposes full clinical hold
FierceBiotech· 3 hours agoBiomea Fusion has suffered another dramatic stock drop, with investors sending the share price down...
FDA places full clinical hold on Biomea Fusion’s diabetes trials of BMF-219
Clinical Trials Arena via Yahoo Finance· 7 hours agoIn October last year, the company received FDA clearance for an investigational new drug (IND)...
This Pharma Stock Dropped 60% Premarket As FDA Halted Diabetes Drug Trials - Biomea Fusion...
Benzinga· 5 hours agoWhat Happened: The FDA’s decision was driven by concerns over potential drug-induced hepatotoxicity...
Scotiabank cuts Biomea Fusion shares target, notes FDA clinical hold concerns By Investing.com
Investing.com· 3 hours agoInc. (NASDAQ: BMEA) shares, reducing it to $21.00 from the previous $41.00. The adjustment follows...
What's the Difference Between Ozempic and Metformin, and Which One Is Right for You?
Parade via Yahoo News· 1 day agoWhat Is Ozempic, and How Does It Work? Ozempic is a GLP-1 medication approved by the FDA for...
U.S. FDA places clinical hold on Biomea's diabetes trials
Reuters via AOL· 18 hours agoThe drug, BMF-219, was being tested in an early-to-mid stage study for type 2 diabetes and a...
Study: High levels of xylitol associated with heart attack, stroke risk
AOL· 14 hours agoA new study finds people who consume high levels of the sweetener xylitol are at a greater risk of...
FDA warns parents to avoid infant formula distributed by Texas company due to contamination
Associated Press· 7 days agoThe same bacteria sparked recalls and shortages of infant formula in 2022 after it was detected at a...
Why Is Biomea Fusion (BMEA) Stock Down 63% Today?
InvestorPlace· 3 hours agoBiomea Fusion (NASDAQ:BMEA) stock is falling hard on Friday after announcing a clinical hold has been put on its Phase I/II clinical trials of BMF-219....